Biogen logo

Biogen (BIIB) Q3 2024 Earnings

BIIB·Reported October 30, 2024·Before market open

Biogen reported Q3 2024 revenue of $2.5B, beat analyst consensus of $2.4B by $31.3M. Diluted EPS came in at $4.08, beat the $3.77 consensus by $0.31.

Revenue
$2.5Bbeat by $31.3M
Consensus: $2.4B
Diluted EPS
$4.08beat by $0.31
Consensus: $3.77
SEC

SEC Filings

Earnings release8-K · 0001193125-24-247628
Quarterly report10-Q · 0000875045-24-000032

Financial Snapshot

Trailing eight quarters through Q3 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Biogen's Q3 2024 earnings report.

Biogen (BIIB) reported Q3 2024 earnings on October 30, 2024 before market open.

Biogen reported revenue of $2.5B and diluted EPS of $4.08 for Q3 2024.

Revenue beat the consensus estimate of $2.4B by $31.3M. EPS beat the consensus estimate of $3.77 by $0.31.

You can read the 8-K earnings release (0001193125-24-247628) and the 10-Q periodic report (0000875045-24-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.